Jennifer Butler

Jennifer Butler

Alston & Bird

Contact
View Bio
RSS

Latest Posts › Prescription Drugs

Share:

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

1/21/2019  /  Department of Health and Human Services (HHS) , Drug Pricing , Prescription Drugs , SAMHSA

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

12/24/2018  /  ACOs , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Fee-for-Service , Food and Drug Administration (FDA) , HRSA , Medicare , Opioid , Prescription Drugs , SAMHSA

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

12/10/2018  /  Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , PDUFA , Pharmaceutical Industry , Prescription Drugs

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

11/5/2018  /  ACOs , Ambulatory Surgery Centers , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , HRSA , Medicare Part B , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs , Section 340B

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

10/22/2018  /  Advertising , Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , GAO , Pharmaceutical Industry , Prescription Drugs , Television Commercials

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

10/15/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicare Part D , Prescription Drugs

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

10/8/2018  /  Dietary Supplements , Food and Drug Administration (FDA) , Medical Devices , Pharmaceutical Industry , Prescription Drugs

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

10/1/2018  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drug Coverage , Prescription Drugs , Section 503

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

9/17/2018  /  Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Medical Devices , Pharmaceutical Industry , Prescription Drugs

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

9/4/2018  /  Department of Veterans Affairs , Food and Drug Administration (FDA) , HRSA , Opioid , Pharmaceutical Industry , Prescription Drugs , Veterans

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

7/2/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Opioid , Pharmaceutical Industry , Physicians , Prescription Drugs , Section 340B

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

6/18/2018  /  Biologics , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Devices , Pharmaceutical Industry , Prescription Drugs , SAMHSA

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

6/11/2018  /  Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Pharmaceutical Industry , Prescription Drugs

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

6/4/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Prescription Drugs , Section 340B

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

5/7/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HCPCS , Health Care Providers , Medicare , Prescription Drugs , Section 340B

Alston & Bird Healthcare Week In Review

I. Regulations, Notices, & Guidance - On February 26, 2018, the Food and Drug Administration (FDA) issued a final order entitled, Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test....more

3/5/2018  /  Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Medical Devices , Medicare , Prescription Drugs

Alston & Bird Healthcare Week In Review

I. Regulations, Notices, & Guidance - On February 20, 2018, the Department of Health and Human Services (HHS) issued a proposed rule entitled, Short-Term, Limited-Duration Insurance. The rule contains proposals amending the...more

2/26/2018  /  Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medical Devices , Pharmaceutical Industry , Prescription Drugs

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On May 6, 2016, the Centers for Medicare & Medicaid Services (CMS) issued an interim final rule entitled, “Patient Protection and Affordable Care Act; Amendments to Special...more

5/18/2016  /  Affordable Care Act , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , GAO , Managed Care Contracts , Medicare , Medicare Advantage , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , PTAC

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On April 21, 2016, CMS issued a proposed rule entitled, “Medicare Program: FY 2017 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirements.” This...more

4/28/2016  /  1099s , Affordable Care Act , Biologics , Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , HCPCS , Health Care Providers , Health Savings Accounts , Hospice , HRSA , Inpatient Prospective Payment System (IPPS) , Inpatient Quality Reporting , Inpatient Rehab Facilities , IRS , Legislative Agendas , Long Term Care Facilities , Medicaid , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Medicare Part B , OIG , Opioid , Physician Medicare Reimbursements , Prescription Drugs , SAMHSA , Section 340B , Skilled Nursing Facility , Traumatic Brain Injuries , Veterans

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On April 15, 2016, the Food and Drug Administration (FDA) issued a proposed rule entitled, “Applications for Approval and Combinations of Active Ingredients Under Consideration for...more

4/21/2016  /  Abbreviated New Drug Application (ANDA) , Affordable Care Act , AHRQ , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , CGMP , Department of Health and Human Services (HHS) , DSCSA , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , HRSA , IRS , Legislative Agendas , Medicaid , Medical Devices , Medicare , OIG , Overpayment , Pharmaceutical Industry , Prescription Drugs , Public Health Insurance Marketplace , Tax Liability

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On April 4, 2016, the Centers for Medicare & Medicaid Services (CMS) issued the Final Calendar Year (CY) 2017 Medicare Advantage Capitation Rates and Medicare Advantage (MA) and...more

4/8/2016  /  Affordable Care Act , Biologics , Cancer , Centers for Medicare & Medicaid Services (CMS) , Department of Veterans Affairs , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Legislative Agendas , Medicaid , Medical Devices , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Medicare Advantage , Medicare Part D , OIG , OMB , Organ Donation , Over The Counter Derivatives (OTC) , Prescription Drugs , Qualified Health Plans , SAMHSA , Vaccinations , Veterans

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On March 29, 2016, Centers for Medicare & Medicaid Services (CMS) issued a final rule entitled, “Medicaid and Children’s Health Insurance Programs: Mental Health Parity and...more

4/1/2016  /  Affordable Care Act , AHRQ , Americans with Disabilities Act (ADA) , Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Controlled Substances Act , Cost-Sharing , Department of Health and Human Services (HHS) , Equal Employment Opportunity Commission (EEOC) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Labeling , Legislative Agendas , Medicaid , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Mental Health , MIPS , OMB , Prescription Drugs , SAMHSA , Substance Abuse , Title I , Vaccinations , Wellness Programs

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On March 24, 2016, the Food and Drug Administration (FDA) issued a guidance entitled, “Draft Guidance for Industry: General Principles for Evaluating the Abuse Deterrence of Generic...more

3/25/2016  /  Affordable Care Act , Biologics , Cancer , CCIIO , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Controlled Substances Act , DEA , Department of Health and Human Services (HHS) , Department of Justice (DOJ) , Food and Drug Administration (FDA) , HCPCS , Legislative Agendas , Medicaid , Medical Devices , Medical Reimbursement , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Medicare Part D , Native American Issues , Opioid , Pharmaceutical Industry , Prescription Drugs , Public Health Insurance Marketplace , Stem cells , Toxic Exposure , Zika

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On March 15, 2016, the Centers for Disease Control and Prevention (CDC) issued voluntary guidelines entitled, “CDC Guidelines for Prescribing Opioids for Chronic Pain — United...more

3/18/2016  /  Affordable Care Act , Biosimilars , Cancer , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Chiropractors , Cost-Sharing , Department of Defense (DOD) , Department of Health and Human Services (HHS) , Department of Veterans Affairs , Drug & Alcohol Abuse , Enrollment , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , Health Insurance Portability and Accountability Act (HIPAA) , HRSA , Information Requests , Insurance Industry , Legislative Agendas , MACPAC , Medicaid , Medical Devices , Medicare , MedPAC , National Institute of Health (NIH) , Native American Issues , Outpatient Services , Patent Applications , Physicians , Prescription Drugs , Reinsurance , Vaccinations , Veterans

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On March 8, 2016, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule entitled, “Medicare Program; Part B Drug Payment Model.” The proposed rule seeks...more

3/11/2016  /  Affordable Care Act , Biologics , Cancer , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Veterans Affairs , Food and Drug Administration (FDA) , Generic Drugs , Health Care Providers , Hospitals , Legislative Agendas , Long Term Care Facilities , Medicaid , Medical Devices , Medicare , Medicare Part B , Native American Issues , Physician Fee Schedule , Physician Medicare Reimbursements , Prescription Drugs , Public Health Service Act , Rural Areas , Rural Health Care Program , Skilled Nursing Facility , Telehealth , Veterans
27 Results
 / 
View per page
Page: of 2
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide